Scientist, Preclinical Ophthalmology Research
Listed on 2026-08-22
-
Research/Development
Research Scientist
Job Title: Scientist, Ophthalmology Research
Company: Elixirgen Therapeutics
Elixirgen Therapeutics is a startup biotech company developing cutting‑edge therapies for rare and aging‑associated diseases with one program in a Phase 1/2 trial. The company is inviting applications for a Scientist specializing in preclinical ophthalmology research to join our dynamic team in advancing both the current and emerging therapeutics development programs.
Role:
The Scientist will carry out experiments, contribute to cross‑functional collaborations, and may potentially play a supervisory role within research teams. We are looking for someone who is highly motivated, committed to therapeutic innovation, and driven to tackle complex challenges in translational research. The successful candidate will hold a doctoral degree and demonstrate deep expertise in ophthalmological research and rare and common diseases of the eye.
Skills:
We’re seeking individuals that bring hands‑on experience in one or more of the following:
- Developing and validating mouse/rat models of AMD, diabetic retinopathy, inherited retinal dystrophies, Stargardt disease, Usher syndrome, etc.
- Molecular Biology (Molecular cloning, PCR, qRT‑PCR, Western blot, ELISA, Genome editing)
Offer:
-Competitive salary commensurate with experience
-Comprehensive benefits package including retirement plans and health insurance
-Mission-Driven Culture: direct impact on life‑changing therapies for diseases without cures
Application Process:
To apply, please submit a CV and statement explaining your interest – why you are interested in this opportunity.
Applications should be emailed to i or submitted via Linkedin Jobs.
The interview process includes a phone interview and an in‑person interview at our office in Baltimore.
As part of the interview process, we will ask for up to 3 professional references.
#J-18808-Ljbffr(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).